Base to Base biotech podcast 57: Keeping drugs cool, and treatment resistant depression
ELREXFIO improves progression-free survival for patients with relapsed or refractory multiple myeloma
Aragen launches India’s first women-led chemistry synthesis laboratory
Vaccine strategy induces broadly neutralising HIV antibodies
Skin damage protein ID could lead to new therapies
Origami Therapeutics and Ipsen to advance protein degrader programme
IQVIA and Boehringer Ingelheim announce data collaboration
Next-generation biopreservation for cell therapy
Predicting cancer evolution
Base to Base biotech podcast 45: Chronic pain, urology, Affibody molecules and radioligand therapy
Johnson & Johnson prostate cancer drug receives CHMP positive opinion
Breakthru Medicine emerges from stealth to develop cancer drugs